These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 21224010)
1. Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice. Semple K; Yu Y; Wang D; Anasetti C; Yu XZ Biol Blood Marrow Transplant; 2011 Mar; 17(3):309-18. PubMed ID: 21224010 [TBL] [Abstract][Full Text] [Related]
2. HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease. Li J; Heinrichs J; Haarberg K; Semple K; Veerapathran A; Liu C; Anasetti C; Yu XZ J Immunol; 2015 Jul; 195(2):717-25. PubMed ID: 26048147 [TBL] [Abstract][Full Text] [Related]
3. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD. Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018 [TBL] [Abstract][Full Text] [Related]
4. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo. Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease. Le HT; Keslar K; Nguyen QT; Blazar BR; Hamilton BK; Min B Front Immunol; 2020; 11():181. PubMed ID: 32117306 [TBL] [Abstract][Full Text] [Related]
6. Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease. Beres A; Komorowski R; Mihara M; Drobyski WR Clin Cancer Res; 2011 Jun; 17(12):3969-83. PubMed ID: 21558402 [TBL] [Abstract][Full Text] [Related]
7. CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity. Beres AJ; Haribhai D; Chadwick AC; Gonyo PJ; Williams CB; Drobyski WR J Immunol; 2012 Jul; 189(1):464-74. PubMed ID: 22649199 [TBL] [Abstract][Full Text] [Related]
8. Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse. Iamsawat S; Tian L; Daenthanasanmak A; Wu Y; Nguyen HD; Bastian D; Yu XZ Blood Adv; 2019 Dec; 3(24):4187-4201. PubMed ID: 31856270 [TBL] [Abstract][Full Text] [Related]
9. Generation of allo-antigen-specific induced Treg stabilized by vitamin C treatment and its application for prevention of acute graft versus host disease model. Kasahara H; Kondo T; Nakatsukasa H; Chikuma S; Ito M; Ando M; Kurebayashi Y; Sekiya T; Yamada T; Okamoto S; Yoshimura A Int Immunol; 2017 Dec; 29(10):457-469. PubMed ID: 29126272 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models. Duramad O; Laysang A; Li J; Ishii Y; Namikawa R Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405 [TBL] [Abstract][Full Text] [Related]
11. CD8(+) Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4(+) Tregs in mice. Heinrichs J; Li J; Nguyen H; Wu Y; Bastian D; Daethanasanmak A; Sofi MH; Schutt S; Liu C; Jin J; Betts B; Anasetti C; Yu XZ Oncoimmunology; 2016 Jun; 5(6):e1146842. PubMed ID: 27471614 [TBL] [Abstract][Full Text] [Related]
12. Prevention of allogeneic cardiac graft rejection by transfer of ex vivo expanded antigen-specific regulatory T-cells. Takasato F; Morita R; Schichita T; Sekiya T; Morikawa Y; Kuroda T; Niimi M; Yoshimura A PLoS One; 2014; 9(2):e87722. PubMed ID: 24498362 [TBL] [Abstract][Full Text] [Related]
13. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice]. Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372 [TBL] [Abstract][Full Text] [Related]
15. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. Giorgini A; Noble A J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039 [TBL] [Abstract][Full Text] [Related]
16. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells. Huang H; Dawicki W; Zhang X; Town J; Gordon JR J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943 [TBL] [Abstract][Full Text] [Related]
17. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT. Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB Front Immunol; 2018; 9():3104. PubMed ID: 30733722 [TBL] [Abstract][Full Text] [Related]
18. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. Tawara I; Shlomchik WD; Jones A; Zou W; Nieves E; Liu C; Toubai T; Duran-Struuck R; Sun Y; Clouthier SG; Evers R; Lowler KP; Levy RB; Reddy P J Immunol; 2010 Oct; 185(7):3866-72. PubMed ID: 20810991 [TBL] [Abstract][Full Text] [Related]
19. TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. Zhang H; Podojil JR; Chang J; Luo X; Miller SD J Immunol; 2010 Jun; 184(12):6629-36. PubMed ID: 20483764 [TBL] [Abstract][Full Text] [Related]
20. Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation. Albert MH; Liu Y; Anasetti C; Yu XZ Eur J Immunol; 2005 Sep; 35(9):2598-607. PubMed ID: 16078276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]